Latest Breaking News On - Khushboo singh - Page 1 : vimarsana.com

UP Shocker: Woman refuses to undergo abortion, her live-in partner chops her into two

, Dec 16 (IANS) The Deoria police in Uttar Pradesh have arrested a man who brutally murdered his live-in partner because she refused to undergo an abortion.According to the police, the unidentified body of a young woman was found in two pieces .

UP Shocker: Woman refuses to undergo abortion, her live-in partner chops her into two

BW Education Super 30 Top Education Brands Awards Summit 2023 Celebrates Excellence In Education

Mumbai: FPJ Felicitates 25 High Scorers In Board Exams From BMC Schools; Education Officer, Actor Adah Sharma Grace The Occasion

I stand up: Time for art to be created for Asians by Asians

Patna: Doctor, wife held for attempted murder of gym trainer

Octogenarian mother donates kidney to save son's life

Octogenarian mother donates kidney to save son's life

UMass cancer researchers make breakthrough, but say that much work remains

UMass cancer researchers make breakthrough, but say that much work remains Posted May 09, 2021 UMass Distinguished Professor in Chemistry Sankaran “Thai” Thayumanavan says progress in cancer research has been made, but more steps must now be taken.UMass Amherst photo / John Solem Facebook Share AMHERST Whenever a breakthrough in cancer research is announced, the natural public reaction is to ask for a timetable and the sooner, the better. That is unfortunately not how such research can work. Nonetheless, a University of Massachusetts Amherst team’s declaration of progress is cause for optimism and hope. “Research usually takes a long time to make an impact. We’ve been working on this for quite a few years,” said Sankaran “Thai” Thayumanavan, a distinguished professor of chemistry and interim head of the UMass biomedical engineering department.

UMass Amherst researchers achieve breakthrough in the fight against cancer

UMass Amherst researchers achieve breakthrough in the fight against cancer A team of researchers at the Center for Bioactive Delivery at the University of Massachusetts Amherst s Institute for Applied Life Sciences has engineered a nanoparticle that has the potential to revolutionize disease treatment, including for cancer. This new research, which appears today in Angewandte Chemie, combines two different approaches to more precisely and effectively deliver treatment to the specific cells affected by cancer. Two of the most promising new treatments involve delivery of cancer-fighting drugs via biologics or antibody-drug conjugates (ADCs). Each has its own advantages and limitations. Biologics, such as protein-based drugs, can directly substitute for a malfunctioning protein in cells. As a result, they have less serious side effects than those associated with traditional chemotherapy. But, because of their large size, they are unable to get into specific cells. ADCs, on the other